TradingView
RocketTickers
١١ تشرين الأول أكتوبر ٢٠٢١ ١٧:١٩
Enzyvant Receives FDA Approval for RETHYMIC® (allogeneic process
NYSE:MYOV
الوصف
⋅
١١ تشرين الأول أكتوبر ٢٠٢١ ١٧:١٩
MYOV: Enzyvant
2021-10-09 20:09:51
Enzyvant Receives FDA Approval for RETHYMIC® (allogeneic processed thymus tissue-agdc), a One-Time Regenerative Tissue-Based Therapy for Pediatric Congenital Athymia
Beyond Technical Analysis
المزيد